drugset / Trial / NCT01684462
The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In this clinical study, the efficacy and safety of ALbumin is to be evaluated for the patients occurred within 12 hours of acute ischemic stroke.
Timeline
- Start
- 2012-09
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human serum albumin | Protein / enzyme biologic | 1.25 g/kg | Intravenous |